Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Back to Journals International Journal of Nanomedicine Volume 20 Aspirin in Cancer Therapy: Pharmacology and Nanotechnology Advances Authors Laila UE , Zhao ZL, Lui H, Xu ZX Received 9 November 2024 Accepted for publication 4 February 2025 Published 23 February 2025 Volume 2025:20 Pages 23272365 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Professor Eng San Thian Umm E Laila, Zi Lon Zhao, Huai Liu, Zhi-Xiang Xu School of Life Sciences, Henan University, Kaifeng, Henan Province, 475001, Peoples Republic of China Correspondence: Zhi-Xiang Xu, School of Life Sciences, Henan University, Kaifeng, Peoples Republic of China, Email [email protected] Abstract: Aspirin, a non-steroidal anti-inflammatory drug (NSAID), has garnered significant attention for its anti-cancer potential
We recommend that you aim for an appointment one to two days before the date in question
The expression changes of Nox1 are closely associated with neurotoxin-induced acute injury (102)
Data analysed by two-way repeated measures ANOVA to assess main effects of treatment ( b and c )
Vital signs are within normal limits
This powerful molecule neutralizes free radicals and supports cellular detoxification pathways
US$ 29.29
US$ 25.17
US$ 20.68
US$ 29.50
US$ 24.15
US$ 24.18
US$ 26.90
US$ 25.24
US$ 28.00
